Showing 48 out of 6,274 results
Tech and digital infrastructure – Increased activity and scrutiny
2024 should see an uptick in deals across the sector but regulatory attention is never far away
Pharma – Strong year ahead
Despite economic and geopolitical disruption last year, biopharma M&A remained resilient and looks set for a busy 2024
Financing – Finding certainty
Heightened interest rates have dampened enthusiasm for M&A and raised questions on how to fund deals
Global M&A Outlook 2024 – Regional perspectives
Asia – The dragons awaken
2024 promises to be a stronger year for M&A as economic stability returns and dealmakers normalise geopolitical uncertainty
Africa – Challenging times
A drop in venture capital activity and ongoing economic headwinds resulted in a sluggish year for deals, but 2024 shows signs of improvement
Australia – Strong again
Activity Australian M&A deal value in 2023 exceeded 2022 levels, despite an approximate 10% decline in deal volume. Strong Australian M&A deal …
Germany – Does M&A need to adapt to a new normal?
With the decrease in deal activity appearing to have bottomed out by the end of 2023, easing inflation and financing costs spark cautious optimism for …
France – The year for a comeback?
After another challenging year, the French M&A market needs to show resilience and adaptability ahead of any rebound
India – Primed for growth
Despite the potential for political shifts, a strong pipeline of deals and increased attention from private capital means 2024 could be a strong year …
Italy – Growing resilience
2023 confirmed the robustness of Italian M&A as market operators learn to live with uncertainty
Europe – Grounds for optimism
Despite weaker deal activity in 2023, the year ahead warrants cautious optimism amid improved economic forecasts and other market forces
Showing 48 out of 6,274 results
View more